FABP1 and metabolic dysfunction-associated steatotic liver disease: The findings of the present study revealed increased protein levels of PPAR-α, CPT1A, and FABP1 and decreased PPAR-γ in the hepatic, cardiac, and renal tissues of the NAFLD animals.